| DRAVPe02224 |
Tricyclic peptide RP 71955 |
CLGIGSCNDFAGCGYAVVCFW |
HIV-1 |
8286361;,8270499 |
| DRAVPe02226 |
Dermaseptin-3 |
ALWKNMLKGIGKLAGKAALGAVKKLVGAES |
HIV-1 |
7989335 |
| DRAVPe02227 |
GNCP-2 |
RRCICTTRTCRFPYRRLGTCLFQNRVYTFCC |
HIV-1 |
8173076 |
| DRAVPe02236 |
LEDGF/p75 (355-377) |
IHAEIKNSLKIDNLDVNRCIEAL |
HIV-1 |
18331842 |
| DRAVPe02250 |
Siamycin II |
CLGIGSCNDFAGCGYAIVCFW |
HIV-1 |
7787424, 7797448 |
| DRAVPe02251 |
Siamycin I (Bacteriocin) |
CLGVGSCNDFAGCGYAVVCFW |
HIV-1 |
8557614, 7797448 |
| DRAVPe02265 |
Mirabamide A |
XXXAGXXXKTGX |
HIV-1 |
30154377;, 17963357 |
| DRAVPe02266 |
Mirabamide B |
XXXAGXXXVTGX |
HIV-1 |
30154377;, 17963357 |
| DRAVPe02267 |
Mirabamide C |
XXXAGXXXKTGX |
HIV-1 |
30154377;, 17963357 |
| DRAVPe02268 |
Mirabamide D |
XXXAGXXXKTGX |
HIV-1 |
30154377;, 17963357 |
| DRAVPe02269 |
Mirabamide E |
XXAGXXXXKVGXX |
HIV-1 |
30154377;,21280591 |
| DRAVPe02270 |
Mirabamide F |
XXAGXXXXKVGXX |
HIV-1 |
21280591 |
| DRAVPe02271 |
Labyrinthopeptin A1 |
SNASVWECCSTGSWVPFTCC |
DENV,ZIKV,WNV,HCV,CHIKV,KSHV,CMV,HSV-2,HIV-1 |
31666384,23724015 |
| DRAVPe02274 |
Lunatusin |
KTCENLADTFRGPCFATSNC |
HIV |
16269344 |
| DRAVPe02275 |
Maculatin 1.1 |
GLFVGVLAKVAAHVVPAIAEHF |
HIV |
16140737 |
| DRAVPe02276 |
Maximin H1 |
ILGPVISTIGGVLGGLLKNL |
HIV |
11835991 |
| DRAVPe02288 |
NP-06 |
CLGVGSCNDFAGCGYAIVCFW |
HIV-1 |
8619594 |
| DRAVPe02289 |
Palustrin-3AR |
GIFPKIIGKGIVNGIKSLAKGVGMKVFKAGLNNIGNTGCNNRDEC |
HIV-1 |
16140737 |
| DRAVPe02290 |
Plantaricin NC8 α |
LTTKLWSSWGYYLGKKARWNLKHPYVQF |
LGTV,IAV,HIV-1.SARS-CoV-2 |
36449554 |
| DRAVPe02297 |
Retrocyclin-3 |
RICRCICGRRICRCICGR |
HIV-1 |
15210812 |
| DRAVPe02300 |
Sesquin |
KTCENLADTY |
HIV-1 |
15949629 |
| DRAVPe02301 |
Siamycin I |
CLGVGSCNDFAGCGYAVVCFW |
HIV-1,HIV-2 |
8557614 |
| DRAVPe02302 |
Siamycin II |
CLGIGSCNDFAGCGYAIVCFW |
HIV |
7787424 |
| DRAVPe02305 |
Temporin-PTa |
FFGSVLKLIPKIL |
HIV-1 |
30669255 |
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.